Medication info
Posalin Tablet 10 mg (Dapagliflozin Propanediol Monohydrate)

Posalin Tablet 10 mg (Dapagliflozin Propanediol Monohydrate)

Prescription medicationTabletOral
Ingredient · strength
Dapagliflozin Propanediol Hydrate›12.3mg / 1 tablet
Manufacturer / importer
Hwanin Pharmaceutical Co., Ltd.
Appearance
Yellow, double convex, diamond-shaped film-coated tablet
Packaging
28 tablets/box [(7 tablets/Alu-Alu x 4)], 28 tablets/bottle, 30 tablets/bottle
Approval status
Active

MFDS item code 202200440 · Approved 2022.01.27 · Insurance code 657203950

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who takes it
Adults · Children
Adult dose
Type 2 diabetes mellitus Monotherapy and add-on combination therapy The recommended dose of this medicine is 10mg once daily for monotherapy and add-on combination therapy with other glucose-lowering agents, such as insulin. When this medicine is used in combination with insulin or an insulin secretagogue such as a sulfonylurea, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy For patients with no previous experience of antidiabetic drug therapy, the recommended initial dose of this medicine when administered in combination with metformin is 5mg once daily or 10mg once daily. Special populations Renal impairment - eGFR less than 45 mL/min/1.73m2: Use of this medicine to improve glycemic control is not recommended. - Patients on dialysis: Do not administer this medicine. Hepatic impairment No dose adjustment is necessary in patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, a starting dose of 5 mg is recommended. If well tolerated, this dose may be increased to 10mg. Elderly patients (≥ 65 years) Dose adjustment based on age is not recommended. Method of administration This medicine may be administered orally once daily at any time of day, with or without food. The tablet should be swallowed whole.
Child dose
The efficacy and safety of dapagliflozin in children under 18 years of age have not been established. No relevant data are available.

Ingredients

Manufacturer
Hwanin Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

  • Type 2 diabetes
  • blood sugar control abnormalities
  • cardiovascular disease
  • cardiovascular risk factors
View approved original text

This medication is used along with diet and exercise therapy to help control blood sugar in patients with type 2 diabetes. It can be administered alone or in combination with other medications. It may be used particularly in patients with cardiovascular disease or risk factors who have not achieved adequate blood sugar control. This drug effectively improves patients' blood sugar levels and aids in the management of cardiovascular risk, playing an important role in the treatment of type 2 diabetes.

How to take

Adult dose

Type 2 diabetes mellitus Monotherapy and add-on combination therapy The recommended dose of this medicine is 10mg once daily for monotherapy and add-on combination therapy with other glucose-lowering agents, such as insulin. When this medicine is used in combination with insulin or an insulin secretagogue such as a sulfonylurea, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy For patients with no previous experience of antidiabetic drug therapy, the recommended initial dose of this medicine when administered in combination with metformin is 5mg once daily or 10mg once daily. Special populations Renal impairment - eGFR less than 45 mL/min/1.73m2: Use of this medicine to improve glycemic control is not recommended. - Patients on dialysis: Do not administer this medicine. Hepatic impairment No dose adjustment is necessary in patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, a starting dose of 5 mg is recommended. If well tolerated, this dose may be increased to 10mg. Elderly patients (≥ 65 years) Dose adjustment based on age is not recommended. Method of administration This medicine may be administered orally once daily at any time of day, with or without food. The tablet should be swallowed whole.

Child dose

The efficacy and safety of dapagliflozin in children under 18 years of age have not been established. No relevant data are available.

Precautions

This medication should not be used in patients with allergies to the active ingredient or excipients, patients with type 1 diabetes, diabetic ketoacidosis, and those undergoing dialysis. Use with caution in patients with reduced fluid volume or impaired kidney function. This medication may lower blood pressure or affect kidney function, so it's important to closely monitor fluid status and kidney function before and after administration. The blood sugar control effectiveness of this medication may vary depending on kidney function, and it is not recommended for patients with moderate to severe renal impairment. This medication may cause side effects such as genital infections, urinary tract infections, hypoglycemia, dehydration, and ketoacidosis, so if any unusual symptoms occur, immediate consultation with healthcare professionals is necessary. Particularly, genital infections may occur more frequently in women, so attention to hygiene is important, and appropriate treatment is necessary if infection symptoms develop. When used with insulin or sulfonylureas, which may cause hypoglycemia, there may be an increased risk of hypoglycemia, so dose adjustments may be necessary. Women who are pregnant or breastfeeding should avoid using this medication, and if pregnancy is confirmed, discontinuation should occur immediately. Elderly patients or those with impaired kidney function should use this medication with caution, and signs of reduced fluid volume and low blood pressure should be closely monitored. This medication does not significantly affect the ability to drive or operate machinery, but caution is required due to the risk of hypoglycemia. In the case of overdose, there are no specific antidotes, so prompt treatment based on symptoms should be sought, and appropriate management should follow the physician's instructions. Regular consultations with healthcare professionals to monitor kidney function, blood pressure, blood sugar, and signs of infection during the use of this medication are important.

Side effects

Vulvovaginitis, balanitic and related genital infections, urinary tract infections, fungal infections, perineal necrosis, hypoglycemia, decreased fluid volume, thirst, diabetic ketoacidosis, dizziness, constipation, dry mouth, lumbago, dysuria, polyuria, nocturia, interstitial nephritis, vulvar pruritus, genital pruritus, increased hematocrit, decreased creatinine clearance in the early stages of treatment, dyslipidemia, elevated serum creatinine in the early stages of treatment, increased blood urea, weight loss, acute pyelonephritis, rash, angioedema, asthenia, pain, keratitis, chronic obstructive pulmonary disease, hemoptysis, cerebral hemorrhage, peripheral artery occlusion, angina pectoris, myocardial infarction, choledocholithiasis, cholangitis, alcoholic cirrhosis, depression, suicide attempt, gastric adenocarcinoma, anaphylaxis, sensory abnormalities, cerebral infarction, nerve compression, urosepsis, pyelonephritis, chest pain, edema, fever, foreign body sensation, facial edema, facial pain, warmth, flu-like symptoms, breast mass, erectile dysfunction, benign prostatic hyperplasia, breast pain, genital rash, menorrhagia, genital edema, uterine bleeding, vaginal bleeding, discomfort in the vulva, menstrual irregularities, hair loss, dermatitis, dry skin, allergic dermatitis, contact dermatitis, diabetic foot ulcer, sweating disorders, eczema, coin-shaped eczema, eczema, hyperkeratosis, nail pigmentation, skin lesions, urticaria, cold sweats, flank pain, fibromyalgia, limb discomfort, muscle cramps, musculoskeletal discomfort, osteopenia, contusion, traffic accident, drug overdose, ankle fracture, orbital fracture, foot fracture, gastrointestinal foreign body, hand fracture, iliac fracture, laceration, ligament tear, limb injuries, meniscus injury, skin abrasion, tendon rupture, thoracic spine fracture, tibial fracture, dental injury, dry eye, ocular pain, retinal disorders, vision loss, blepharitis, cataract, conjunctival edema, allergic conjunctivitis, conjunctivitis, diplopia, eyelid edema, keratitis, ocular hypertension, visual impairment, vitreous floaters, oropharyngeal pain, allergic rhinitis, asthma, voice disorders, epistaxis, sputum, sleep apnea syndrome, wheezing, atherosclerosis, flushing, peripheral coldness, varicose veins, vascular headache, orthostatic hypotension, atrial fibrillation, diastolic dysfunction, palpitations, anxiety disorders, nocturia, hallucinations, sleep disorders, insomnia, fatty liver, gallbladder polyp, tinnitus, altered taste, drowsiness, tension headache, carpal tunnel syndrome, diabetic neuropathy, unconsciousness, neuralgia, peripheral neuropathy, sleep disorders, syncope, tremors, bronchitis, shingles, sinusitis, tonsillitis, diverticulitis, herpes simplex, stye, joint abscess, laryngitis, otitis media, pelvic inflammatory disease, periodontitis, pneumonia, pulmonary tuberculosis, rhinitis, onychomycosis, herpes simplex, edema, fever, foreign body sensation, facial edema, facial pain, warmth, flu-like symptoms, chest pain, fatigue, pain, edema, foreign body sensation, vaginal discharge, itching, urticaria, cold sweats, arthralgia, musculoskeletal pain, limb pain, myasthenia, myalgia, osteoarthritis, ligament strain, diabetic retinopathy, cough, dyspnea, orthostatic hypotension, palpitations, insomnia, fatty liver, gallbladder polyp, tinnitus

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored tightly sealed to prevent exposure to air or moisture. Additionally, it is safest to store the medication at room temperature, which is not too cold or too hot, specifically between 1 degree and 30 degrees Celsius.

Appearance and packaging

Appearance

Yellow, double convex, diamond-shaped film-coated tablet

Package unit

28 tablets/box [(7 tablets/Alu-Alu x 4)], 28 tablets/bottle, 30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.